Cardiovascular
Rapid Increase In Sclerosant Use Will Drive Steady Expansion Of US Varicose Vein Treatment Device Market
April 4, 2013 8:00 am | by PR Newswire | News | CommentsTORONTO, April 4, 2013 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, growth in the United States market for varicose vein treatment devices will be driven largely by strong growth in the sclerotherapy...
The Heart and Vascular Center Bad Bevensen Treats First Patients in Germany With Hansen Medical's Magellan Robotic System
April 3, 2013 4:03 pm | by The Associated Press | News | CommentsHansen Medical, Inc. (NASDAQ: HNSN), a global leader in intravascular robotics, today announced that the Heart and Vascular Center Bad Bevensen has performed the first successful cases with the Magellan Robotic System in Germany. These cases were performed by Dr. Thomas Nolte, Director...
FDA's New Global Cardiovascular Registry to Start with Transcatheter Heart Valves
April 3, 2013 3:26 pm | by Mass Device | News | CommentsThe FDA plans to launch a global cardiovascular medical device registry, with initial efforts to focus on coordinated efforts to monitor transcatheter heart valve technology. The federal watchdog agency will host a public meeting later this month to discuss goals and strategies for organizing such an effort.
Reimbursement Cuts Will Challenge Japanese Interventional Cardiology Device Market
April 3, 2013 8:00 am | by The Associated Press | News | CommentsAccording to Millennium Research Group (MRG), the global authority on medical technology market intelligence, prices of interventional cardiology devices in Japan will see significant declines through 2021. The Japanese Ministry of Health, Labor and Welfare (MHLW) is implementing ...
FDA Clears Medtronic's Affinity Fusion Blood Oxygenation System
April 2, 2013 2:49 pm | by Mass Device | News | CommentsMedtronic said the FDA granted 510(k) clearance for its Affinity Fusion blood oxygenator, used during open heart surgery to replace the function of the lungs. The Minneapolis-area medical device company, which is the world's largest pure-play medtech maker, said the Affinity Fusion is designed to filter a patient's blood to remove particles and air during oxygenation.
Imaging Technology Could Lower Coronary Disease Mortality Rate
April 2, 2013 12:06 pm | by Purdue Research Park | News | CommentsPatients undergoing angioplasty or other heart-related medical procedures could benefit from a new technology being developed with funding from the National Science Foundation (NSF). Optical imaging technology from Wasatch Photonics Inc. creates images of coronary artery walls in vivo to show where lesions and plaques have formed.
Smart Phone App That Helps Patients Manage Heart Disease
April 2, 2013 11:28 am | by Rutgers-Camden | News | CommentsA new smart phone app that helps patients manage heart disease and stay out of the hospital has been developed by a team led by a Rutgers–Camden nursing student. Shannon Patel led a team that developed the WOW ME 2000mg app to help patients, their caregivers, and their family members identify and manage symptoms of heart failure.
Recent Advancements Made in Diagnosing and Treating Heart Failure Could Save and Improve the Lives of Millions
April 2, 2013 9:01 am | by The Associated Press | News | CommentsSAN DIEGO--(BUSINESS WIRE)--Apr 2, 2013--As recently reported in the Journal of the American College of Cardiology, a Cleveland Clinic pilot study of 41 patients indicated that an experimental breath analysis device may be able to help diagnose patients with heart failure. In much the same way as...
C.R. Bard Loses Patent Round, $25M Hernia Insurance Decision
April 1, 2013 9:54 pm | by Mass Device | News | CommentsC.R. Bard revealed a 1-2 punch today when it reported another loss in its patent infringement war with W.L. Gore and an adverse insurance decision that could cost it $25 million. The medical device company said in regulatory filings that the U.S. Patent & Trademark Office issued an initial finding in its reexamination of a Bard patent for a "Prosthetic vascular graft," known as the '135 patent.
Abiomed Initiates Trial of Right-Side Heart Pump
April 1, 2013 2:38 pm | by Mass Device | News | CommentsAbiomed said the 1st patient to receive its right-side heart pump, the Impella RP, as part of a clinical trial aimed at U.S. approval was implanted with the device in Philadelphia. The Danvers, Mass.-based medical device company said the patient was implanted with the Impella RP after implantation with another type of heart pump called a left ventricular assist device.
Welch Allyn EcoCuffTM Helps Hospitals Control Cross-Contamination, Costs and Environmental Impact
April 1, 2013 8:30 am | by The Associated Press | News | CommentsSKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Apr 1, 2013--Welch Allyn, a leading medical diagnostic device company that specializes in helping clinicians improve patient outcomes, today announced the launch of its new FlexiPort ® EcoCuff TM single-patient-use blood pressure cuff.
New Automated BP Monitor for Stress Tests from SunTech Medical
April 1, 2013 8:15 am | by The Associated Press | News | CommentsMORRISVILLE, N.C.--(BUSINESS WIRE)--Apr 1, 2013--SunTech Medical has updated its line of automated blood pressure monitoring with the Tango® M2 cardiac stress BP monitor. The new product provides accurate BP measurements during exercise and cardiac stress testing where noise and motion often make...
Portable Heart Pump Gives Yarmouth Teen Time
March 30, 2013 12:30 am | by CYNTHIA MCCORMICK - Cape Cod Times - Associated Press | News | CommentsThirteen-year-old Kyah DeSimone wanted to make cheerleading practice and good grades, not medical history. But after a frightening brush with heart failure, the eighth-grader became the first patient at Boston Children's Hospital to be implanted with a heart pump small and portable enough to restore her to normal life while she waits for a transplant.
BDC Laboratories Announces VDT-3600i Heart Valve Accelerated Wear Test System
March 28, 2013 3:37 pm | by The Associated Press | News | CommentsWHEAT RIDGE, Colo.--(BUSINESS WIRE)--Mar 28, 2013--Positive clinical outcomes continue to be reported by researchers worldwide with transcatheter aortic valve implantation (TAVI). Moreover, new technologies are in development and will, in the future, offer additional minimally invasive treatment...
Varian Medical Systems Highlights Calypso® System and Other Technologies Designed to Help Reduce the Risk of Heart Disease after Radiotherapy for Breast Cancer
March 28, 2013 2:48 pm | by PR Newswire | News | CommentsPALO ALTO, Calif., March 28, 2013 /PRNewswire/ -- Varian Medical Systems (NYSE:VAR), the world leader in radiotherapy equipment and software, is highlighting its Calypso® System as a tool designed to help doctors reduce women's risk of developing heart disease years after...
Will Another Durata Failure Report Drag St. Jude Down?
March 28, 2013 1:31 pm | by Mass Device | News | CommentsWall Street didn't move much on news of another insulation-related failure in St. Jude Medical's next-generation Durata defibrillator leads this week. The case report included a detailed analysis of an incident in which a Durata lead failed due to inside-out abrasion...
Biotronik Lands CE Mark for MRI-Safe Iforia Defibrillator
March 28, 2013 12:37 pm | by Mass Device | News | CommentsBiotronik said it's planning a mid-year launch in Europe for its Iforia MRI-safe pacemaker now that EU regulators have given the device CE Mark approval. The German medical device company said the Iforia is the world's 1st ICD/CRT-D device using the DF4 connector to be approved for magnetic resonance imaging, according to a press release.
FDA Makes Vascular Solutions' Catheter Valve Recall Class I
March 28, 2013 11:26 am | by Mass Device | News | CommentsThe FDA slapped its most serious designation on the recall of hemostasis valves made by Vascular Solutions (NSDQ:VASC). The Minneapolis-based company last month recalled its Guardian II and Guardian II NC valves "due to a risk that air may be introduced into the device which may lead to an air embolism," according to the federal watchdog agency.
CardioReady Cautions FDA on New Review for Public Defibrillators
March 28, 2013 7:29 am | by Mass Device | News | CommentsThe FDA this month issued a new proposal on the regulatory oversight of automated external defibrillators, but at least 1 medical device maker is worried that enhanced oversight may harm public safety. Philadelphia-based CardioReady, maker of AED systems, urged that the FDA ensure that any new oversight not jeopardize the proliferation of AEDs, in the interest of public health.
BioControl Medical Makes Progress Toward FDA Review for CardioFit Heart Stim Device
March 26, 2013 1:27 pm | by Mass Device | News | CommentsIsrael and Minnesota-based BioControl Medical won FDA approval to proceed with the 3rd and largest phase of its INOVATE-HF trail, evaluating its CardioFit vagal nerve stimulation system in treatment of heart failure. The global, multi-center trial aims to provide clinical data in support of BioControl's premarket approval application for FDA clearance of the CardioFit system.
Wang's Technology May Answer Host of Medical Questions
March 26, 2013 12:03 pm | by Washington University in St. Louis | News | CommentsIn an engineering breakthrough, a Washington University in St. Louis biomedical researcher has discovered a way to use light and color to measure oxygen in individual red blood cells in real time.
U.S. Food and Drug Administration Approves Full Expansion of BioControl Medical’s INOVATE-HF Study of the CardioFit®
March 26, 2013 7:00 am | by The Associated Press | News | CommentsYEHUD, Israel & NEW HOPE, Minn.--(BUSINESS WIRE)--Mar 26, 2013--BioControl Medical has received U.S. Food and Drug Administration approval to begin the third and largest phase of INOVATE-HF (INcrease Of VAgal TonE in Heart Failure), a global, multi-center, investigational device exemption...
New Cardiac Electrical Biomarker Featured In Johns Hopkins Abstract Demonstrates Strong Correlation To High Sensitivity Troponin To Rule Out Acute Myocardial Ischemic Injury
March 25, 2013 12:20 pm | by The Associated Press | News | CommentsFrom the 2013 American College of Cardiology (ACC) Convention One of the leading complaints in the Emergency Department is chest pain and the timely detection of a heart attack is essential. Because of this, VectraCor, Inc., an emerging medical device company for cardiovascular solutions, is...
Further Advancing Sepsis Therapy
March 25, 2013 10:26 am | by Wyss Institute for Biologically Inspired Engineering at Harvard | News | CommentsThe Wyss Institute for Biologically Inspired Engineering at Harvard University announced that it was awarded a $9.25 million contract from the Defense Advanced Research Projects Agency (DARPA) to further advance a blood-cleansing technology developed at the Institute with prior DARPA support, and help accelerate its translation to humans as a new type of sepsis therapy.
COWIN Helps Sensaris Certify the ZAO Biomedical Sensor
March 25, 2013 10:13 am | by COWIN | News | CommentsSensaris has announced that it has developed a novel, multi-sensor device for monitoring vital signs. Called the ZAO, it is currently going through the certification process and will be available mid 2013. Roughly the same size as a thick paperback book, it is designed to provide professional level diagnostic data so that it can be used by medical professionals and yet its low target volume price point of around €550 means that it can also be used by the home health market.
